MYO

Myomo Inc. Common Stock (MYO)

Stock · AMEX · Health Care

$1.22as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

MYO appoints Mary-Katherine McClure as Chief Commercial Officer. Myomo announced that Mary‑Katherine McClure has been named chief commercial officer. McClure will lead the company’s sales and marketing efforts and oversee commercial strategy. The addition of an experienced executive comes as the stock is trading near a long‑standing support level.

Active signals

Resistance level
$1.24
Industry
Industrial Specialties

What MYO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike38-2.0%50%
Bollinger Band Breakout21+0.3%52%
Bollinger Band BreakdownActive now19+2.5%58%
200-Day Moving Average TouchActive now10+4.9%80%
Any 20-session window (baseline)-3.2%44%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About MYO

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides Myo…

Sector
Health Care
Industry
Industrial Specialties
Employees
194
Website
myomo.com/

Fundamentals

1-day range
$1.22$1.31
Market cap
$50.62M
P/E (trailing)
—
P/E (forward)
-5.91
EPS (trailing)
$-0.34
Dividend yield
—
Beta
1.72
Avg. volume
497.4K
Dividend pay date
January 31, 2020
52-week range
$0.605$1.89
Next earnings: November 9, 2026 · EPS estimate $-0.07confirmed

How Myomo Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$40.93MSG&A$34.35M (84%)Cost of Revenue$14.04M (34%)R&D$6.94M (17%)Tax$504.5K (1%)MYO

Source: 10-K filed Mar 9, 2026 · via SEC EDGAR / Finnhub

Gross Profit$26.89M(66%)
Operating Income-$14.40M(-35%)

Forecasts

5 analyst ratings

Buy 89%
Hold 11%
Sell 0%
1-year price forecast
High
$10.5
+764.2%
Median
$3
+146.9%
Low
$1.7
+39.9%

Myomo Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • MYO
    Myomo Inc. Common Stock
    $1.2
    ▼ 7.69%
    Market cap $50.62MP/E —
    $0.605$1.89
  • COCH
    Envoy Medical Inc. Class A Common Stock
    $0.668
    ▲ 3.57%
    Market cap $52.34MP/E —
    $0.3625$0.9539
  • APT
    Alpha Pro Tech Ltd. Common Stock
    $5.55
    ▼ 2.97%
    Market cap $53.33MP/E 14.66
    $4.34$7.5
  • MAMO
    Massimo Group Common Stock
    $0.926
    ▼ 0.43%
    Market cap $44.56MP/E 9.77
    $0.66$5.59
  • MLSS
    Milestone Scientific Inc. Common Stock
    $0.33
    ▲ 0.00%
    Market cap $41.13MP/E —
    $0.2181$0.5796
  • ADSEW
    ADS-TEC ENERGY PLC Warrant
    $0.21
    ▼ 4.33%
    Market cap $38.90MP/E —
    $0.14$1.37
  • NTRB
    Nutriband Inc. Common Stock
    $6.22
    ▼ 0.80%
    Market cap $35.43MP/E —
    $2.8$9.19

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
426.1K
Disposed
139.7K

Institutional Ownership

March 31, 2026

Total shares held
12.38M
Total value held
$8.21M
Institutional holders
77
Top holders this quarter
  • Unknown3.85M
  • Unknown1.69M
  • Unknown1.14M
  • Unknown858.8K
  • Unknown704.3K
  • Unknown425.6K
  • Unknown383.2K
  • Unknown370.3K
  • Unknown319.0K
  • Unknown311.7K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.